Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats
Open Access
- 7 June 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (5) , 1185-1194
Abstract
Background and purpose: Oestrogen loss at menopause is frequently related to poor wound healing. Genistein has been tested in anti‐ageing cosmetic preparations with interesting results on skin health. Here, we investigated the effects of the genistein aglycones, given systemically, in an incisional model of wound healing, compared to systemic oestradiol and raloxifene.Experimental approach: Six months after ovariectomy (OVX), rats were randomly assigned to groups of 12 animals each and treated daily with genistein aglycone (1 and 10 mg·kg−1 s.c.), raloxifene hydrochloride (0.05 and 0.5 mg·kg−1 s.c.) or 17‐α‐ethinyl oestradiol (0.003 and 0.03 mg·kg−1 s.c.) for 12 weeks. Untreated OVX and sham OVX rats were used as controls. Then, 14 or 7 days before the end of the experiment, an incisional wound healing procedure was performed and skin specimens were collected to evaluate molecular, histological and functional measurements.Key results: Seven and fourteen days after wounding, samples from OVX rats showed a decrease in transforming growth factor‐β1, tissue transglutaminase 2 and vascular endothelial growth factor compared to samples from sham OVX rats. Oestradiol, raloxifene and genistein all significantly modified this decrease, but the lowest genistein dose exerted a greater effect than the other treatments. Moreover, the lowest dose of genistein was the most effective in improving skin healing and wound tensile strength.Conclusions and implications: Genistein aglycone might be an alternative therapy for the management of skin wound healing.Keywords
This publication has 58 references indexed in Scilit:
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Genistein aglycone reverses glucocorticoid‐induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronateBritish Journal of Pharmacology, 2009
- Transforming growth factor β1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balancePostgraduate Medical Journal, 2009
- Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiolBritish Journal of Pharmacology, 2008
- Soy isoflavones in the management of postmenopausal osteoporosisMenopause, 2008
- Estrogen enhances wound healing in the penis of ratsBiomedical Research, 2008
- Isoflavones made simple – Genistein’s agonist activity for the beta-type estrogen receptor mediates their health benefitsMedical Hypotheses, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Topical Estrogen Accelerates Cutaneous Wound Healing in Aged Humans Associated with an Altered Inflammatory ResponseThe American Journal of Pathology, 1999
- Long‐term effects of the menopause and sex hormones on skin thicknessBJOG: An International Journal of Obstetrics & Gynaecology, 1985